ES466606A1 - Procedimiento para la preparacion de heterociclos aminoal- cohilicos. - Google Patents

Procedimiento para la preparacion de heterociclos aminoal- cohilicos.

Info

Publication number
ES466606A1
ES466606A1 ES466606A ES466606A ES466606A1 ES 466606 A1 ES466606 A1 ES 466606A1 ES 466606 A ES466606 A ES 466606A ES 466606 A ES466606 A ES 466606A ES 466606 A1 ES466606 A1 ES 466606A1
Authority
ES
Spain
Prior art keywords
carbon atoms
hydrogen
alkyl
trifluoromethyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES466606A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES466606A1 publication Critical patent/ES466606A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
ES466606A 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos. Expired ES466606A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (de) 1976-03-09 1976-03-09 Aminoalkylheterocyclen

Publications (1)

Publication Number Publication Date
ES466606A1 true ES466606A1 (es) 1978-10-01

Family

ID=5971857

Family Applications (10)

Application Number Title Priority Date Filing Date
ES456622A Expired ES456622A1 (es) 1976-03-09 1977-03-08 Procedimiento para la preparacion de heterociclos aminoalco-hilicos.
ES466606A Expired ES466606A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466605A Expired ES466605A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466604A Expired ES466604A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466598A Expired ES466598A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466603A Expired ES466603A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoalco-hilicos.
ES466602A Expired ES466602A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466600A Expired ES466600A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466599A Expired ES466599A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466601A Expired ES466601A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoalco-hilicos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES456622A Expired ES456622A1 (es) 1976-03-09 1977-03-08 Procedimiento para la preparacion de heterociclos aminoalco-hilicos.

Family Applications After (8)

Application Number Title Priority Date Filing Date
ES466605A Expired ES466605A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466604A Expired ES466604A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466598A Expired ES466598A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466603A Expired ES466603A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoalco-hilicos.
ES466602A Expired ES466602A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466600A Expired ES466600A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466599A Expired ES466599A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES466601A Expired ES466601A1 (es) 1976-03-09 1978-02-03 Procedimiento para la preparacion de heterociclos aminoalco-hilicos.

Country Status (36)

Country Link
US (4) US4154829A (es)
JP (2) JPS52108970A (es)
AT (1) AT360542B (es)
AU (1) AU515953B2 (es)
BE (1) BE852223A (es)
BG (4) BG27743A3 (es)
CA (1) CA1086317A (es)
CH (8) CH630358A5 (es)
CS (2) CS220320B2 (es)
DD (1) DD130037A5 (es)
DE (1) DE2609645A1 (es)
DK (1) DK102177A (es)
ES (10) ES456622A1 (es)
FI (1) FI69070C (es)
FR (2) FR2343731A1 (es)
GB (1) GB1571231A (es)
GR (1) GR64553B (es)
HK (1) HK12884A (es)
HU (1) HU177953B (es)
IE (1) IE45300B1 (es)
IL (1) IL51627A (es)
LU (1) LU76898A1 (es)
MX (1) MX4878E (es)
MY (1) MY8500079A (es)
NL (1) NL7702403A (es)
NO (1) NO147950C (es)
NZ (1) NZ183536A (es)
PH (3) PH16110A (es)
PL (2) PL112937B1 (es)
PT (1) PT66282B (es)
RO (3) RO79706A (es)
SE (1) SE435059B (es)
SG (1) SG55583G (es)
SU (4) SU698530A3 (es)
YU (1) YU62377A (es)
ZA (1) ZA771412B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
BE883068A (fr) 1979-05-04 1980-08-18 Continental Pharma Derives de benzimidazole, leur preparation, et utilisation ainsi que compositions contenant ces derives
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (de) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (es) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
DE69711519T2 (de) 1996-09-05 2002-10-31 Lilly Co Eli Carbazolanaloge als selektive beta3-adrenergische Agonisten
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
SI1598340T1 (sl) 2001-04-18 2009-08-31 Euro Celtique Sa Derivati 1-(4-piperidinil)-1,3-dihidro-2H-benzoksazol-2-ona in sorodne spojine kot analogi nociceptina in ligandi ORL1 za zdravljenje bolečine
AU2002311833B2 (en) 2001-04-18 2005-04-28 Euro-Celtique S.A. Spiropyrazole compounds
IL158486A0 (en) * 2001-04-18 2004-05-12 Euro Celtique Sa Nociceptin analogs
DK1975164T3 (da) 2001-04-18 2010-05-25 Euro Celtique Sa Octahydrobenzimidazolon-forbindelser som analgetika
EP2033644A1 (en) 2001-04-18 2009-03-11 Euro-Celtique S.A. Spiroindene and spiroindane compounds
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
MXPA05005661A (es) * 2002-11-27 2005-11-23 Artesian Therapeutics Inc Compuestos con actividad antagonista o antagonista parcial mixta inhibidora de fosfodiesterasa y beta-adrenergica para el tratamiento de insuficiencia cardiaca.
US20070117978A1 (en) * 2002-12-23 2007-05-24 Artesian Therapecutics, Inc Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102004001413A1 (de) * 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
EP1830852A2 (en) * 2004-11-30 2007-09-12 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
WO2006060122A2 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102005007654A1 (de) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
MX2008001976A (es) * 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
DE102005052102A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052101A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
JP2009526817A (ja) * 2006-02-16 2009-07-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療用医薬組成物
PE20080142A1 (es) 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion
CA2660186A1 (en) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands
WO2009026227A2 (en) * 2007-08-16 2009-02-26 The University Of Mississippi Highly selective sigma receptor ligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 L. Clark Robert Substituted benzimidazolones
CH149009A (de) * 1929-08-10 1931-08-15 Chem Ind Basel Verfahren zur Darstellung einer N-substituierten Verbindung der Pyridonreihe.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (es) * 1961-10-24
FR1516714A (fr) * 1962-11-07 1968-02-05 Bayer Ag Procédé de préparation de dérivés de l'imidazolidine
FR1384708A (fr) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Perfectionnements aux dispositifs de mise en place d'objets
BE659364A (es) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (es) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
CA1086317A (en) 1980-09-23
PH17635A (en) 1984-10-18
IL51627A (en) 1980-10-26
SG55583G (en) 1984-07-27
RO76589A (ro) 1981-04-30
DK102177A (da) 1977-09-10
HU177953B (en) 1982-02-28
JPS52108970A (en) 1977-09-12
ES466601A1 (es) 1978-10-01
FR2372810A1 (fr) 1978-06-30
IE45300L (en) 1977-09-09
ZA771412B (en) 1978-11-29
SE7702609L (sv) 1977-10-11
ES466604A1 (es) 1978-10-01
RO70569A (ro) 1981-11-24
ES466603A1 (es) 1978-10-01
ES456622A1 (es) 1978-03-16
CH630358A5 (de) 1982-06-15
CH630361A5 (de) 1982-06-15
SE435059B (sv) 1984-09-03
FI770586A (es) 1977-09-10
IL51627A0 (en) 1977-05-31
FI69070C (fi) 1985-12-10
BG28053A4 (en) 1980-02-25
ES466605A1 (es) 1978-10-01
DE2609645A1 (de) 1977-09-15
CH630365A5 (de) 1982-06-15
PT66282B (pt) 1979-01-17
PH16149A (en) 1983-07-12
AU515953B2 (en) 1981-05-14
ES466598A1 (es) 1978-10-01
US4215119A (en) 1980-07-29
SU685149A3 (ru) 1979-09-05
HK12884A (en) 1984-02-24
PL112937B1 (en) 1980-11-29
CS220320B2 (en) 1983-03-25
NZ183536A (en) 1981-11-19
SU698530A3 (ru) 1979-11-15
FR2343731A1 (fr) 1977-10-07
PL111240B1 (en) 1980-08-30
NO147950C (no) 1983-07-13
ATA122377A (de) 1980-06-15
NO147950B (no) 1983-04-05
US4363814A (en) 1982-12-14
PL196505A1 (pl) 1979-06-18
US4154829A (en) 1979-05-15
CH630359A5 (de) 1982-06-15
FR2372810B1 (es) 1982-11-26
JPS6172A (ja) 1986-01-06
ES466602A1 (es) 1978-10-01
LU76898A1 (es) 1978-06-01
BG27743A3 (en) 1979-12-12
ES466600A1 (es) 1978-10-01
GB1571231A (en) 1980-07-09
DD130037A5 (de) 1978-03-01
BG28052A4 (en) 1980-02-25
PT66282A (pt) 1977-04-01
RO79706A (ro) 1982-08-17
BE852223A (fr) 1977-09-08
AU2300977A (en) 1978-09-14
CS209435B2 (en) 1981-12-31
NL7702403A (nl) 1977-09-13
IE45300B1 (en) 1982-07-28
CH630363A5 (de) 1982-06-15
MX4878E (es) 1982-11-26
SU676163A3 (ru) 1979-07-25
YU62377A (en) 1982-10-31
SU683616A3 (ru) 1979-08-30
PH16110A (en) 1983-06-30
MY8500079A (en) 1985-12-31
ES466599A1 (es) 1978-10-01
CH630364A5 (de) 1982-06-15
CH630362A5 (de) 1982-06-15
CH630360A5 (de) 1982-06-15
US4271158A (en) 1981-06-02
FI69070B (fi) 1985-08-30
AT360542B (de) 1981-01-12
FR2343731B1 (es) 1982-02-26
GR64553B (en) 1980-04-14
NO770804L (no) 1977-09-12
BG28051A4 (en) 1980-02-25

Similar Documents

Publication Publication Date Title
ES466598A1 (es) Procedimiento para la preparacion de heterociclos aminoal- cohilicos.
ES464136A1 (es) Procedimiento para la preparacion de derivados de quinazolo-na.
ES436124A1 (es) Un procedimiento para la preparacion de derivados de pira- zol.
ES414159A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-fenilamino-imidazolina-(2).
IE44014L (en) Amino-benzocycloheptenes.
ES465225A1 (es) Procedimiento para la preparacion de n-cicloalcohilmetil-2- fenilamino-imidazolinas-(2).
GB2117762B (en) 4-phenyl-4 5 6 7-tetrahydro-thieno (2 3-clpyridines)
SE8300432L (sv) Reaktiva kanelsyraderivat for framstellning av biologiskt aktiva amider
SE7908940L (sv) Nya acyl-1h-1,2,4-triazolderivat
SE7606497L (sv) Substituerade 4-fenylimidazoliner, deras syraadditinossalter och forfarande for framstellning derav
ES497560A0 (es) Un procedimiento para la preparacion de nuevos derivados de oxazolina y tiazolina
ES488705A1 (es) Procedimiento para la preparacion de endo-aril-exo-pirrolin-amidinas
GB2006762A (en) Chroman Derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000103